111723 Alzheimer’s CME Info

ACKNOWLEDGEMENT

This activity is supported by an independent medical education grant from Eisai, Inc.

DATE OF RELEASE/EXPIRATION

This activity was released on November 17th, 2023 and is valid until November 17th, 2024. Requests for credit must be made no later than November 17th, 2024.

TARGET AUDIENCE

The educational design of this activity addresses the needs of – neurologists, geriatricians, specialty advanced practitioners, and primary care physicians.

STATEMENT OF NEED/PROGRAM OVERVIEW

Biologic infusion therapies, including anti-amyloid monoclonal antibodies, are now available for the treatment of people with mild cognitive impairment (MCI) and early Alzheimer’s disease. Early diagnosis, an understanding of new biomarkers, and strategies to address adverse events are crucial to fully leveraging the potential of these new therapies in the clinic and ensuring that each patient receives the right treatment.

Join a neurologist and a representative from the National Infusion Center Association (NICA) to review the importance of and strategies for identifying and diagnosing patients with MCI and early Alzheimer’s disease. Panelists will discuss how to differentiate the mechanisms of action and the rationale for use of new and emerging anti-amyloid therapies, share strategies to enhance access to infusion centers and mitigate treatment-related adverse events, and explore ways to ensure patients and caregivers have the support they need to help break patient-related barriers.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Communicate treatment expectations to patients and families
• Review solutions to orient patients and families to access complex biologic infusion therapies for Alzheimer’s disease
• Identify educational resources and advocacy groups to support patients with Alzheimer’s disease at all disease stages
• Develop strategies to monitor and mitigate imaging abnormalities and bleeding risk with anti-amyloid infusion therapy

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION

PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a score of 75% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

FACULTY AND DISCLOSURE OF CONFLICTS OF INTEREST

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For additional information about the accreditation of this activity, please visit https://partnersed.com.

Technical Support:

For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive at 877-394-1306 or at Support@PsychiatryCareLive.com.